Diabetology International
Inappropriate use of GLP-1-based antiobesity medications: beyond appropriate drug use toward appropriate weight reduction
ReviewInterventions
The paper
Kobe University
Diabetology International, 26 Aug 2026
Related
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
